Form 8-K - Current report:
SEC Accession No. 0001193125-25-142735
Filing Date
2025-06-18
Accepted
2025-06-18 16:23:13
Documents
13
Period of Report
2025-06-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d935264d8k.htm   iXBRL 8-K 25069
  Complete submission text file 0001193125-25-142735.txt   170557

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA rvmdw-20250618.xsd EX-101.SCH 3911
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rvmdw-20250618_def.xml EX-101.DEF 13294
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE rvmdw-20250618_lab.xml EX-101.LAB 21820
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rvmdw-20250618_pre.xml EX-101.PRE 14198
15 EXTRACTED XBRL INSTANCE DOCUMENT d935264d8k_htm.xml XML 5511
Mailing Address 700 SAGINAW DR REDWOOD CITY CA 94063
Business Address 700 SAGINAW DR REDWOOD CITY CA 94063 415-766-3638
Revolution Medicines, Inc. (Filer) CIK: 0001628171 (see all company filings)

EIN.: 472029180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39219 | Film No.: 251057253
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)